The last-mile healthcare delivery across 1,100 villages, with focus on maternal health, diagnostics, and chronic disease management
The drug meets all primary endpoints across 608 patients in Europe and India, strengthening the company's biosimilars pipeline
Searches for diabetes, heart conditions, and metabolism-related risks are rising sharply, with Tier 2 cities outpacing metros in specialist consultations
Veteran HR leader comes with over two decades of experience to spearhead talent strategy, leadership development, and culture transformation
New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Safety was equally impressive. ENV-294 was well tolerated
They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market
Institute signs four MoUs, launches two products and marks 75 years with renewed focus on lab-to-market commercialisation
ANDA approval for 100 mg and 150 mg capsules targeting idiopathic pulmonary fibrosis opens access to a $3.76 billion market in USA
71-year-old high-risk patient with atrial fibrillation and ventricular tachycardia discharged next day
Subscribe To Our Newsletter & Stay Updated
